E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1819, Issue 5, 2012, Pages 446-453

  Hyndman, Brandy D ^a   Thompson, Patrick ^a   Bayly, Richard ^a   Côté, Graham P ^a   LeBrun, David P ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

CBP; Chromatin immunoprecipitation; E2A; Gene transcription; Histone acetyltransferase; P300

Indexed keywords

AMINO ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; PLASMID DNA; PROTEIN P300; RECOMBINANT PROTEIN; RECOMBINANT TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CATALYSIS; DNA FLANKING REGION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ACETYLATION; AMINO ACID SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CREB-BINDING PROTEIN; HEK293 CELLS; HISTONE ACETYLTRANSFERASES; HOMEODOMAIN PROTEINS; HUMANS; ONCOGENE PROTEINS, FUSION; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION;

EID: 84857926456     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2012.02.009     Document Type: Article

References (31)

1. de Pooter R.F., Kee B.L. E proteins and the regulation of early lymphocyte development. Immunol. Rev. 2010, 238:93-109.
2. Greenbaum S., Lazorchak A.S., Zhuang Y. Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes. J. Biol. Chem. 2004, 279:45028-45035.
3. Lin Y.C., Jhunjhunwala S., Benner C., Heinz S., Welinder E., Mansson R., Sigvardsson M., Hagman J., Espinoza C.A., Dutkowski J., Ideker T., Glass C.K., Murre C. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 2010, 11:635-643.
4. Bayly R., Chuen L., Currie R.A., Hyndman B.D., Casselman R., Blobel G.A., LeBrun D.P. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J. Biol. Chem. 2004, 279:55362-55371.
5. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 2004, 68:1145-1155.
6. Visel A., Rubin E.M., Pennacchio L.A. Genomic views of distant-acting enhancers. Nature 2009, 461:199-205.
7. Bradney C., Hjelmeland M., Komatsu Y., Yoshida M., Yao T.P., Zhuang Y. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 2003, 278:2370-2376.
8. Eckner R., Yao T.P., Oldread E., Livingston D.M. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 1996, 10:2478-2490.
9. Qiu Y., Sharma A., Stein R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol. Cell. Biol. 1998, 18:2957-2964.
10. LeBrun D.P. E2a basic helix-loop-helix transcription factors in human leukemia. Front. Biosci. 2003, 8:S206-S222.
11. Bayly R., Murase T., Hyndman B.D., Savage R., Nurmohamed S., Munro K., Casselman R., Smith S.P., LeBrun D.P. Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Mol. Cell. Biol. 2006, 26:6442-6452.
12. Kraus W.L., Manning E.T., Kadonaga J.T. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol. Cell. Biol. 1999, 19:8123-8135.
13. Berndsen C.E., Denu J.M. Assays for mechanistic investigations of protein/histone acetyltransferases. Methods 2005, 36:321-331.
14. Martinez-Balbas M.A., Bannister A.J., Martin K., Haus-Seuffert P., Meisterernst M., Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 1998, 17:2886-2893.
15. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 2006, 1:179-185.
16. Hyndman B.D., Thompson P., Denis C.M., Chitayat S., Bayly R., Smith S.P., LeBrun D.P. Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation. Biochim. Biophys. Acta 2011, 1819:375-381.
17. Winston F., Allis C.D. The bromodomain: a chromatin-targeting module?. Nat. Struct. Biol. 1999, 6:601-604.
18. Horiuchi K., Fujimoto D. Use of phosph-cellulose paper disks for the assay of histone acetyltransferase. Anal. Biochem. 1975, 69:491-496.
19. Mizzen C.A., Brownell J.E., Cook R.G., Allis C.D. Histone acetyltransferases: preparation of substrates and assay procedures. Methods Enzymol. 1999, 304:675-696.
20. Reeves R., Gorman C.M., Howard B. Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res. 1985, 13:3599-3615.
21. Visel A., Blow M.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F., Afzal V., Ren B., Rubin E.M., Pennacchio L.A. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009, 457:854-858.
22. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., Ching K.A., Antosiewicz-Bourget J.E., Liu H., Zhang X., Green R.D., Lobanenkov V.V., Stewart R., Thomson J.A., Crawford G.E., Kellis M., Ren B. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
23. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
24. Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., An W., Ge Q., Roeder R.G., Wong J., Levrero M., Sartorelli V., Cotter R.J., Cole P.A. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 2004, 11:308-315.
25. Shen W.F., Krishnan K., Lawrence H.J., Largman C. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol. Cell. Biol. 2001, 21:7509-7522.
26. Zhao F., Carrick-Walmsley R., Akerblad P., Sigvardsson M., Kadesch T. Inhibition of p300/CBP by early B-cell factor. Mol. Cell. Biol. 2003, 23:3837-3846.
27. Hong W., Kim A.Y., Ky S., Rakowski C., Seo S.B., Chakravarti D., Atchison M., Blobel G.A. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1. Mol. Cell. Biol. 2002, 22:3729-3743.
28. Soutoglou E., Viollet B., Vaxillaire M., Yaniv M., Pontoglio M., Talianidis I. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 2001, 20:1984-1992.
29. Hoffmann A., Barz T., Spengler D. Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity. Mol. Cell. Biol. 2006, 26:5544-5557.
30. Monica K., LeBrun D.P., Dedera D.A., Brown R.B., Cleary M.L. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol. Cell. Biol. 1994, 14:8304-8314.
31. Bayly R., LeBrun D.P. Role for homodimerization in growth deregulation by E2a fusion proteins. Mol. Cell. Biol. 2000, 20:5789-5796.